Investment Analysts’ Updated EPS Estimates for August 3rd (ALMS, AUTL, AZN, BIOA, BTSG, CTEC, DTIL, EVMN, FBIZ, FDM)
Investment Analysts’ updated eps estimates for Monday, August 3rd: Alumis (NASDAQ:ALMS) had its neutral rating reaffirmed by analysts at HC Wainwright. They currently have a $25.00 target price on the stock. Autolus Therapeutics (NASDAQ:AUTL) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $10.00 target price on the stock. […]
3 Aug 17:44 · The Markets Daily